Idera Pharmaceuticals downgraded by JMP Securities
$IDRA
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
JMP Securities downgraded Idera Pharmaceuticals from Outperform to Market Perform
Save time and jump to the most important pieces.